Sample Type |
Sample Number GC |
Sample Number nonGC |
Method |
Region |
Hpylori |
Normal vs. GC |
Early-stage vs. Advanced stage |
Biological Functions in GC Cells |
Result |
PMID |
tissue |
40 |
40 |
qRT-PCR |
China |
No Reports |
Down |
- |
- |
Downregulated in GC tumor tissues; miR‑320a is negatively correlated with ADAM10 in tumors |
29152656 |
cell line |
- |
- |
Colony formation assay; MTS assay; Viability assay |
- |
No Reports |
- |
- |
- |
miR‑320a inhibits cell growth and enhances sensitivity of GC cells to cisplatin and suppresses tumor growth in vivo. |
29152656 |
cell line |
- |
- |
Luciferase reporter assay |
- |
No Reports |
- |
- |
- |
miR‑320a directly targets ADAM10 in GC cells. |
29152656 |
tissue |
14 |
14 |
qRT-PCR |
China |
No Reports |
Down |
- |
- |
miR-320a expression is decreased in human gastric cancer tissues and correlates inversely with expression of FoxM1, a key cell cycle regulator involved in gastric carcinoma. By contrast, the expression of P27KIP1, a downstream effector of FoxM1, correlates positively with miR-320a levels. |
27086911 |
cell line |
- |
- |
Clone formation assay |
- |
No Reports |
- |
- |
miR-320a inhibits gastric cancer cell proliferation by suppressing activity in the FoxM1-P27KIP1 axis. |
miR-320a inhibits gastric cancer cell proliferation by suppressing activity in the FoxM1-P27KIP1 axis. |
27086911 |
mice |
- |
- |
Xenograft mice models |
- |
No Reports |
- |
- |
- |
nude mice injected with BGC-823 gastric cancer cells expressing a miR-320a inhibitor exhibit faster tumor growth than mice injected with control cells. |
27086911 |
cell line |
- |
- |
Luciferase reporter assay |
- |
No Reports |
- |
- |
- |
FoxM1 is a direct target of miR-320a |
27086911 |